FDx Advisors Inc. lifted its position in shares of Danaher Corporation (NYSE:DHR) by 6.1% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 36,768 shares of the conglomerate’s stock after buying an additional 2,127 shares during the quarter. FDx Advisors Inc.’s holdings in Danaher Corporation were worth $3,154,000 at the end of the most recent quarter.
Other hedge funds and other institutional investors have also recently modified their holdings of the company. FMR LLC grew its holdings in Danaher Corporation by 0.3% in the first quarter. FMR LLC now owns 19,441,167 shares of the conglomerate’s stock valued at $1,662,803,000 after purchasing an additional 53,429 shares during the period. Advantus Capital Management Inc grew its holdings in Danaher Corporation by 0.7% in the first quarter. Advantus Capital Management Inc now owns 61,392 shares of the conglomerate’s stock valued at $5,251,000 after purchasing an additional 439 shares during the period. Lakeview Capital Partners LLC purchased a new stake in Danaher Corporation in the first quarter valued at approximately $265,000. Citizens Financial Group Inc. RI grew its holdings in Danaher Corporation by 12.6% in the first quarter. Citizens Financial Group Inc. RI now owns 102,785 shares of the conglomerate’s stock valued at $8,791,000 after purchasing an additional 11,539 shares during the period. Finally, Teachers Advisors LLC grew its holdings in Danaher Corporation by 8.0% in the first quarter. Teachers Advisors LLC now owns 1,039,182 shares of the conglomerate’s stock valued at $88,881,000 after purchasing an additional 76,571 shares during the period. Institutional investors and hedge funds own 75.56% of the company’s stock.
COPYRIGHT VIOLATION NOTICE: “FDx Advisors Inc. Purchases 2,127 Shares of Danaher Corporation (DHR)” was first published by Sports Perspectives and is the property of of Sports Perspectives. If you are accessing this story on another site, it was stolen and reposted in violation of US & international trademark and copyright law. The original version of this story can be read at https://sportsperspectives.com/2017/11/23/fdx-advisors-inc-purchases-2127-shares-of-danaher-corporation-dhr.html.
Danaher Corporation (NYSE:DHR) opened at $93.76 on Thursday. Danaher Corporation has a 12-month low of $76.27 and a 12-month high of $94.24. The company has a debt-to-equity ratio of 0.42, a quick ratio of 1.00 and a current ratio of 1.43. The company has a market cap of $65,512.09, a price-to-earnings ratio of 24.21, a PEG ratio of 2.24 and a beta of 1.02.
Danaher Corporation (NYSE:DHR) last posted its quarterly earnings results on Thursday, October 19th. The conglomerate reported $1.00 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.95 by $0.05. The firm had revenue of $4.53 billion for the quarter, compared to analysts’ expectations of $4.47 billion. Danaher Corporation had a net margin of 13.36% and a return on equity of 11.29%. The firm’s quarterly revenue was up 9.6% on a year-over-year basis. During the same period in the prior year, the company posted $0.87 earnings per share. research analysts anticipate that Danaher Corporation will post 3.99 EPS for the current year.
The business also recently declared a quarterly dividend, which was paid on Friday, October 27th. Investors of record on Friday, September 29th were issued a $0.14 dividend. The ex-dividend date of this dividend was Thursday, September 28th. This represents a $0.56 annualized dividend and a yield of 0.60%. Danaher Corporation’s dividend payout ratio is presently 16.52%.
In related news, CAO Robert S. Lutz sold 11,189 shares of the company’s stock in a transaction on Monday, October 23rd. The shares were sold at an average price of $91.66, for a total value of $1,025,583.74. Following the sale, the chief accounting officer now directly owns 18,314 shares of the company’s stock, valued at $1,678,661.24. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider William King sold 43,688 shares of the company’s stock in a transaction on Thursday, August 31st. The shares were sold at an average price of $82.86, for a total transaction of $3,619,987.68. Following the completion of the sale, the insider now directly owns 45,748 shares in the company, valued at $3,790,679.28. The disclosure for this sale can be found here. Insiders sold 317,498 shares of company stock worth $28,838,801 over the last ninety days. 12.20% of the stock is currently owned by corporate insiders.
A number of equities research analysts recently issued reports on the stock. Robert W. Baird boosted their target price on shares of Danaher Corporation from $87.00 to $97.00 and gave the company an “outperform” rating in a report on Friday, October 20th. Credit Suisse Group lifted their price target on shares of Danaher Corporation from $93.00 to $96.00 and gave the company an “outperform” rating in a research report on Friday, October 20th. Morgan Stanley lifted their price target on shares of Danaher Corporation from $95.00 to $98.00 and gave the company an “overweight” rating in a research report on Friday, October 20th. Zacks Investment Research raised shares of Danaher Corporation from a “hold” rating to a “buy” rating and set a $97.00 price target on the stock in a research report on Thursday, October 5th. Finally, J P Morgan Chase & Co reaffirmed an “overweight” rating and set a $95.00 price target on shares of Danaher Corporation in a research report on Friday, September 8th. One analyst has rated the stock with a sell rating, four have issued a hold rating, thirteen have given a buy rating and one has given a strong buy rating to the stock. Danaher Corporation presently has an average rating of “Buy” and an average price target of $93.31.
Danaher Corporation Company Profile
Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR).
Receive News & Ratings for Danaher Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher Corporation and related companies with MarketBeat.com's FREE daily email newsletter.